Director · LIGAND PHARMACEUTICALS INC · Common Stock
Side
SELL
Value
$58K
Shares
232
Price
$248.11
Executed
Jun 10, 2026
Disclosed
Jun 12, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jun 10 executedJun 12, 2026 disclosed
LGND · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
3 prior trades recorded in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Lamattina John L filed this Form 4 reporting a open-market sale of LGND on Jun 10, 2026. It became public on Jun 12, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Lamattina John Lcik:0001216074
Issuer
LIGAND PHARMACEUTICALS INCcik:0000886163
Revision history · 0
No field has changed since this record was first ingested.
